These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25442113)

  • 1. Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress.
    Xu Y; Pan J; Sun J; Ding L; Ruan L; Reed M; Yu X; Klabnik J; Lin D; Li J; Chen L; Zhang C; Zhang H; O'Donnell JM
    Neurobiol Aging; 2015 Feb; 36(2):955-70. PubMed ID: 25442113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic GMP-mediated memory enhancement in the object recognition test by inhibitors of phosphodiesterase-2 in mice.
    Lueptow LM; Zhan CG; O'Donnell JM
    Psychopharmacology (Berl); 2016 Feb; 233(3):447-56. PubMed ID: 26525565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway.
    Xu Y; Pan J; Chen L; Zhang C; Sun J; Li J; Nguyen L; Nair N; Zhang H; O'Donnell JM
    Int J Neuropsychopharmacol; 2013 May; 16(4):835-47. PubMed ID: 22850435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase-2 inhibitor reverses post-traumatic stress induced fear memory deficits and behavioral changes via cAMP/cGMP pathway.
    Chen L; Liu K; Wang Y; Liu N; Yao M; Hu J; Wang G; Sun Y; Pan J
    Eur J Pharmacol; 2021 Jan; 891():173768. PubMed ID: 33271150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phosphodiesterase type 2 inhibitor BAY 60-7550 reverses functional impairments induced by brain ischemia by decreasing hippocampal neurodegeneration and enhancing hippocampal neuronal plasticity.
    Soares LM; Meyer E; Milani H; Steinbusch HW; Prickaerts J; de Oliveira RM
    Eur J Neurosci; 2017 Feb; 45(4):510-520. PubMed ID: 27813297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of PDE2 reverses beta amyloid induced memory impairment through regulation of PKA/PKG-dependent neuro-inflammatory and apoptotic pathways.
    Wang L; Xiaokaiti Y; Wang G; Xu X; Chen L; Huang X; Liu L; Pan J; Hu S; Chen Z; Xu Y
    Sci Rep; 2017 Sep; 7(1):12044. PubMed ID: 28935920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.
    Bubb KJ; Trinder SL; Baliga RS; Patel J; Clapp LH; MacAllister RJ; Hobbs AJ
    Circulation; 2014 Aug; 130(6):496-507. PubMed ID: 24899690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of phosphodiesterase 2 reverses gp91phox oxidase-mediated depression- and anxiety-like behavior.
    Huang X; Xiaokaiti Y; Yang J; Pan J; Li Z; Luria V; Li Y; Song G; Zhu X; Zhang HT; O'Donnell JM; Xu Y
    Neuropharmacology; 2018 Dec; 143():176-185. PubMed ID: 30268520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: involvement of antioxidant and anti-apoptotic mechanisms.
    Ding L; Zhang C; Masood A; Li J; Sun J; Nadeem A; Zhang HT; O' Donnell JM; Xu Y
    Behav Brain Res; 2014 Jul; 268():150-158. PubMed ID: 24694839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion.
    van Donkelaar EL; Rutten K; Blokland A; Akkerman S; Steinbusch HW; Prickaerts J
    Eur J Pharmacol; 2008 Dec; 600(1-3):98-104. PubMed ID: 18957291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of phosphodiesterase 2 inhibitor against Aβ
    Yan Y; Gao S; Avasthi S; Zhao Y; Ye J; Tao Y; Wang W; Zhu X; Du F; O'Donnell JM; Xu Y
    Neuropharmacology; 2022 Aug; 213():109128. PubMed ID: 35588859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance.
    Boess FG; Hendrix M; van der Staay FJ; Erb C; Schreiber R; van Staveren W; de Vente J; Prickaerts J; Blokland A; Koenig G
    Neuropharmacology; 2004 Dec; 47(7):1081-92. PubMed ID: 15555642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Sierksma AS; Rutten K; Sydlik S; Rostamian S; Steinbusch HW; van den Hove DL; Prickaerts J
    Neuropharmacology; 2013 Jan; 64():124-36. PubMed ID: 22771768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of phosphodiesterase 2 by Bay 60-7550 decreases ethanol intake and preference in mice.
    Shi J; Liu H; Pan J; Chen J; Zhang N; Liu K; Fei N; O'Donnell JM; Zhang HT; Xu Y
    Psychopharmacology (Berl); 2018 Aug; 235(8):2377-2385. PubMed ID: 29876622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic effects of phosphodiesterase-2 inhibitors associated with increased cGMP signaling.
    Masood A; Huang Y; Hajjhussein H; Xiao L; Li H; Wang W; Hamza A; Zhan CG; O'Donnell JM
    J Pharmacol Exp Ther; 2009 Nov; 331(2):690-9. PubMed ID: 19684253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K; Prickaerts J; Hendrix M; van der Staay FJ; Sik A; Blokland A
    Eur J Pharmacol; 2007 Mar; 558(1-3):107-12. PubMed ID: 17207788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Phosphodiesterase 2 Ameliorates Post-Traumatic Stress-Induced Alcohol Intake Disorder by Regulating cAMP/cGMP Signaling.
    Pan X; Chen L; Shan C; Cai L; Wang Y; Chen Y; Gu M; Liu K; Li P; Pan J
    Int J Neuropsychopharmacol; 2022 Nov; 25(11):936-945. PubMed ID: 36124735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal nitric oxide contributes to neuroplasticity-associated protein expression through cGMP, protein kinase G, and extracellular signal-regulated kinase.
    Gallo EF; Iadecola C
    J Neurosci; 2011 May; 31(19):6947-55. PubMed ID: 21562256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice.
    Masood A; Nadeem A; Mustafa SJ; O'Donnell JM
    J Pharmacol Exp Ther; 2008 Aug; 326(2):369-79. PubMed ID: 18456873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase 2 inhibitor Hcyb1 reverses corticosterone-induced neurotoxicity and depression-like behavior.
    Zhu MJ; Shi J; Chen Y; Huang G; Zhu XW; Zhang S; Huang XF; Song GQ; Zhang HT; Ke HM; O'Donnell JM; Wang LQ; Xu Y
    Psychopharmacology (Berl); 2020 Nov; 237(11):3215-3224. PubMed ID: 32926224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.